Mark Sterckel

Mark Sterckel is an accomplished senior leader in the healthcare industry with extensive experience in patient engagement, innovation, and digital health. He is currently the Managing Director at Sterckel Innovation.13

Professional Experience

Mark has held several key positions throughout his career:

• VP Patient Engagement / Chief Patient Officer at Alexion Pharmaceuticals (July 2022 - September 2023)1
• Senior Director Global Patient Advocacy Neurology at Alexion Pharmaceuticals (July 2022 - September 2023)1
• Sr. Patient Engagement Director at Ferring Pharmaceuticals (July 2020 - July 2022)12
• Patient Partnership Principal Director Personalised Healthcare at Roche (August 2018 - July 2020)12
• Director Learning, Patient Support Programs & Innovation Global Medical Affairs at AbbVie (June 2015 - December 2017)12

Expertise and Skills

Mark is known for:

• Driving patient-centered solutions and innovation in healthcare
• Developing and implementing patient engagement strategies1
• Fostering innovation within large teams1
• Accelerating clinical trial cycles1
• Mentoring leaders and emphasizing cross-functional value1

Education

Mark's educational background includes:

• Exponential Technologies Executive program at Singularity University2
• Innovation practitioner training at ?WhatIf! The Innovation company2
• Lean Six Sigma Blackbelt training at Abbott University2
• BSc in Business Administration & Logistics from Amsterdam University of Applied Sciences2

Personal Qualities

Colleagues describe Mark as:

• Results-driven1
• An articulate and savvy communicator
• A skilled team builder1
• Passionate about patient engagement and innovation1

Mark Sterckel is recognized as an industry veteran with over a decade of experience in patient engagement and healthcare innovation.4